Health Outcomes & Pharmacy Practice

Faculty
Photo of Rascati

Rascati, Karen L., Ph.D.
Centennial Endowed Professor
PHR 3.210
512-471-1637
krascati@mail.utexas.edu

Selective Recent Research Presentations
  1. Rascati KL, Prasla K, Park H, McBayne T. Evaluation of Healthcare Costs for Patients with Gout by Serum Uric Acid. Accepted for American College of Rhematology (ACR) Annual Meeting, Chicago IL November 2011.

  2. Bird AM, Smith TL, Mican LM, Rascati KL. Impact of the CATIE Tiral on Antipsychotic Prescribing Patterns at a State Psychiatric Facility. Annual College of Psychiatric and Neurologic Pharmacists (CPNP) Meeting, Phoenix, AZ, May 2011.

  3. Cheng L, Rascati KL, Trice SK, Lawson KA, Barner JC. Validation of the Updated Charlson Comorbidity Index (CCI) to Predict Healthcare Utilization for Diabetic Patients Using Administrative Data.   International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011. *Awarded Best Student Podium Award

  4. Kim D, Park H, Rascati KL , Measures of medication adherence in orals vs. long-acting risperidone in Texas Medicaid patients with schizophrenia. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011. * Awarded Best Poster Award

  5. Desai P, Chandwani H, Rascati K.  Assessing the Quality of Pharmacoeconomics Studies in India: A Systematic Review.  International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

  6. Park H, Kim DN, Rascati KL. Comparisons of Mental Health-Related Medical Care Utilization and Costs Following the Initiation of Oral vs. Long-Acting Injectable Risperidone in Patients with Schizophrenia. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

  7. Desai P, Lawson K, Barner JC, Rascati KL. Estimation of Direct Costs of Treating Schizophrenia for Community Dwelling Residents in the United States. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

  8. Oladapo AO, Barner JC, Rascati KL, Strassels S.  Examining Adherence with Medications used in Treating Diabetic Peripheral Neuropathic Pain and Their Association with Oral anti-diabetic Medication Adherence.  International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

  9. Gavaza P, Rascati KL, Oladapo AO, Khoza S. The State of Health Economics Evaluation in South Africa: A Systematic Review.  International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

  10. Khoza S, Barner JC, Lawson K, Rascati KL, Wilson JP, Bohman TM.  Use of Antidepressants and the Risk of Diabetes Mellitus: A Retrospective Cohort Study. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

  11. Khoza S, Barner JC, Lawson K, Rascati KL, Wilson JP, Bohman TM.  Use of Antidepressants and the Risk of Diabetes Mellitus: A Nested Case-Control Study. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

  12. Rascati K, Richards K, Stafkey-Mailey D, Ott C, Goddard A, Alvir J,Sanders K. Adherence, Persistence, and Medical Costs Associated with the Use of Clinically Effective Doses of Antipsychotic Medications in Patients with Bipolar Disorder. Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Minneapolis, MN, April 2011

  13. Rascati K, Prasla K, Park H, McBayne T, Comparison of Health Care Costs for Gout Patients by Uric Acid Level Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Minneapolis, MN. April 2011.

  14. Kim YA, Loucks A, Yokoyama G, Lightwood J, Rascati K, Serxner S, Evaluation of a Value-Based Insurance Design in a Large Retail Employer Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Minneapolis, MN, April 2011.

  15. Cheng L, Rascati K, Trice SK, Barner JC, Lawson KA, Performance of Different Comorbidity Measures to Predict Health Care Expenditures, Hospitalizations, and Emergency Department Visits for Patients with Diabetes Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Minneapolis, MN, April 2011.

  16. Park H, Kim YA, Rascati KL, Efficacy and safety of dipeptidyl-peptidase 4 [DPP4] inhibitors in type 2 diabetes: Meta-analysis. American Pharmacists Association (AphA) Annual Meeting & Exposition 2011, Seattle, WA, March 2011. * Awarded 2011 APhA-APRS Postgraduate Best Paper Award-ESAS Poster.

  17. Park H, Rascati KL, Keith MS, Hodgkins P, Smyth M, Goldsmith D, Akehurst l. Cost-effectiveness of lanthanum vs sevelamer hydrochloride for the treatment of hyperphosphatemia in dialysis patients. American Society of Nephrology (ASN),Denver, CO, November 2010.

  18. Park H, Kim YA, Rascati K. Efficacy and Safety of Dipeptidyl-Peptidase 4 [DPP-4] Inhibitors in Type 2 Diabetes:  Meta-Analysis. International Society of Outcomes and Pharmacoeconomics Research 13th Annual European Congress, Prague, Czech Republic, November , 2010.

  19. Kim YA, Prasla K, Rascati K, Goel N, Dunlop D, Knisely E, Godley P. Retrospective Evaluation of the Impact of Cost-Share Increases for Specialty Medications on Adherence and Persistence. International Society of Outcomes and Pharmacoeconomics Research 13th Annual European Congress, Prague, Czech Republic, November , 2010.

  20. Rascati KL, Kim DN. Adherence Rates of Injectable vs. oral Risperidone for Patients with Schizophreia.. International Society of Outcomes and Pharmacoeconomics Research 13th Annual European Congress, Prague, Czech Republic, November , 2010.

  21. Stafkey-Mailey D, Richards K, Rascati K, Ott CA, Goddard A, Alvir J, Sanders K, Mychaskiw MA. Costs Associated with Antipsychotic Medications for Patients with a Bipolar Diagnosis at Clinically Recommended Doses.  International Society of Outcomes and Pharmacoeconomics Research 13th Annual European Congress, Prague, Czech Republic, November , 2010.

  22. Park H, Rascati KL, Keith MS, Hodgkins PS, Smyth MD, Goldsmith D, Akehurst RL. The Cost-Effectiveness of Lanthanum Carbonate vs. Sevelamer HCl in Patients with End-stage Renal Disease. International Society of Outcomes and Pharmacoeconomics Research 13th Annual European Congress, Prague, Czech Republic, November, 2010.

  23. Park H, Rascati K, Keith M,. T Hodgkins P, Smyth M, Goldsmith D, Akehurst he Value of Lanthanum Carbonate Versus Sevelamer Hydrochloride in End-Stage Renal Disease Patients: An Economic Evaluation from a U.S. Payer Perspective. Academy of Managed Care Pharmacy (AMCP) Educational Conference, St. Louis, MO, October  2010.

  24. Rascati KL, Richards K, Ott C, Stafkey-Mailey D, Goddard AW, Sanders K, Alvir J, Mychaskiw M. Adherence Rates for Antipsychotic Medications at Clinically Recommended Doses. NCDEU Annual Meeting, Boca Raton FL, June 2010.

  25. Clinical and Economic Outcomes of a Diabetes Medication Management Program, Kim Y, Prasla K, Rascati K, Tabor T, Juan J, Godley P. ISPOR Annual Meeting, Atlanta, GA May 2010.

  26. Rascati KL, Richards KM, Lopez D, Cheng L, Wilson, JP, Johnsrud M.  Determination of Time to Insulin for Patients with Diabetes Mellitus:  Retrospective Analysis Using Department of Defense Data.  Academy of Managed Care Pharmacy Annual Meeting and Showcase, San Diego, CA, April 2010.

  27. Rascati KL, Richards KM, Lopez D, Cheng L, Wilson, JP, Johnsrud M.  Time to Insulin for Medicaid Patients with Diabetes Mellitus . Academy of Managed Care Pharmacy Educational Conference, San Antonio TX, October 2009.

  28. Rascati KL, Cheng, L, Martin B.  Severity Scoring: Comparison of Methods. Workshop presentation.  ISPOR 2nd Latin America Conference, Rio de Janeiro, Brazil,  September 2009.

  29. Reddy M, Rascati KL, Wilson JP, Nwokeji ED. An Evaluation of Pharmacoeconomics Education in Colleges of Pharmacy Outside the US: 2007-2008 Update.  ISPOR Annual International Meeting.  Orlando, FL, May 2009.

  30. Tiwana SK, Rascati KL.  Expanded Newborn Screening in Texas: A Cost-Effectiveness Analysis. ISPOR Annual International Meeting.  Orlando, FL, May 2009.

  31. Strassels SA, Rascati KL, Wilson JP.  Assessing the Effect of Cost-Sharing on Emergency Department Use by Economically Disadvantaged Persons. ISPOR Annual International Meeting.  Orlando, FL, May 2009.

  32. Bui CN, Hanson KA, Prasla K, Godley PJ, Frech-Tamas F, Rascati KL.  Evaluation of an Educational Antihypertensive Medication Adherence Tool: Impact on Antihypertensive Adherence and Blood Pressure Control. ISPOR Annual International Meeting.  Orlando, FL, May 2009.

  33. Mann TA, Rascati KL, Richards KM, Johnsrud M Anti-epileptic Medication Drug Formulation Changes and Their Relationship to Outcomes.  ISPOR Annual European Conference, Athens Greece November 2008 Winner of Best Student Poster Award.

  34. Nwokeji, E., Rascati, K., Brown C., Eisenberg A. Prescribing long-acting opioid analgesics to patients with moderate to severe chronic nonmalignant pain: a family physicians perspective.  IASP 12th Congress on Pain, Glasgow, Scotland, August 2008.

  35. Gavaza P, Rascati KL, Lawson KA, Brown CM, Mann T.  The State of Health Economics and Pharmacoeconomics Evaluation Research in Zimbabwe. ISPOR Annual International Conference, Toronto, Canada, May 2008.

  36. Conner TM, Hoverman JR, Forsyth M, Rascati KL.  Cost-Analysis of Immunoglobulin Prophylaxis in Chronic Lymphocytic Leukemia. ISPOR Annual International Conference, Toronto, Canada, May 2008.

  37. Brown CM, Rascati KL, Nwokeji ED, Corbell ZD, Phillips GA, Zachry WM.  Examining the Perceived Burden of Prior Authorization of Psychotherapeutics Among Texas Medicaid Prescribers. ISPOR Annual International Conference, Toronto, Canada, May 2008.

  38. Hanson KA, Prasla K, Godley PJ, Tabor T, Juan J, Rascati KL, Klein MS.  Evaluation of Economic Outcomes, Adherence, and Glycemic Control for Diabetic Patients in a Pharmacist-run Medication Management Program. ISPOR Annual International Conference, Toronto, Canada, May 2008.

  39. Yeh JY, Lawson K, Novak S, Rascati KL, Barner JC, Johnsrud M.  Longitudinal Estimates and Cost-effectivenesss Analysis of Anti-resorptive Agents for Glucocorticoid-induced Osteoporosis and Fractures Based on US National Surveys. ISPOR Annual International Conference, Toronto, Canada, May 2008.

  40. Reddy M, Rascati KL, and Wahawisan J.  Pharmacoeconomics Education in Colleges of Pharmacy 2007.  ISPOR Annual European Conference, Dublin Ireland, October 2007.

  41. Yarger SA, Rascati KL, and Leslie RC.  Analysis of the Predictive Ability of Diagnostic Cost Groups, Rx Groups, and Prior Cost for Texas Medicaid COPD Patients. ISPOR Annual European Conference, Dublin Ireland, October 2007. Best Student Poster Award

  42. Nwokeji ED, Eisenburg A, Rascati KL, Brown CM. Examining the Attitudes and Beliefs of Family Physicians Toward the Use of Controlled-Release Opioids for the Treatment of Chronic Non-malignant Pain.Texas Association of Family Physicians 58th Annual Session and Scientific Assembly in Corpus Christi, July 2007.  First Place Poster Award.

  43. Nwokeji E, Rascati KL, Brown CM. Examining Family Physicians' Attitudes and Willingness to Prescribe Long-Acting Opiods to Patients with Moderate to Severe Chronic Non-malignant Pain. ISPOR Annual Meeting, Arlington VA, May 2007.

  44. Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM. Comparison of Events (Hospitalizations and Emergency Department Visits) and Costs for Medicaid Patients with Chronic Obstructive Pulmonary Disease (COPD) by Initial Medication Regimen. ISPOR Annual Meeting, Arlington VA, May 2007.

  45. Prasla K, Godley P, Gabrillo E, Rascati KL.  Medication Adherence in Patients with Diabetes During the Medicare Part D Benefit Coverage Gap Period.  ISPOR Annual Meeting, Arlington VA, May 2007.


More Information About Dr. Rascati
> Current Position
> Selected Recent Publications
> Books / Book Chapters
> Selected Recent Invited Presentations
> Return to Racati's Home Page


(Download PDF Reader.)

Last Reviewed: September 8, 2011

Division Information

Mailing Address:
Pharmacy Administration
College of Pharmacy
The University of Texas
at Austin
2409 University Ave.
Stop A1900
Austin, TX, USA
78712-1113

Email Address: pharmacy
@www.utexas.edu

Phone:
1-512-471-6892


Lawson, Donavan Named to TETA Awards

Dr. Ken Lawson, associate professor of pharmacy administration, and Martin Donavon, a teaching assistant in the division of pharmaceutics, were honored recently when they were named recipients of the Texas Excellence Teaching Awards.
>Read more about these awards.

index of the major headings: a b c d e f g h i j k l m n o p q r s t u v w x y z